Pulmonology Department, Álvaro Cunqueiro University Hospital, Vigo, Spain.
NeumoVigo I + I Research Group, Galicia Sur Health Research Institute (IISGS), Vigo, Spain.
J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):225-231. doi: 10.1089/jamp.2024.0002. Epub 2024 Jun 19.
Despite the importance of an adequate peak inspiratory flow (PIF) during inhaled therapy in patients with COPD, the available evidence in patients with severe exacerbations and their evolution after admission is limited. We conducted this study to evaluate the PIF during an exacerbation, its variability, and predictors of suboptimal PIF. A prospective study that included patients admitted for COPD exacerbation. Clinical, demographic, and functional variables were recorded. Using the In-Check DIAL G16, PIF without resistance (PIF-nr) and that obtained by simulating the resistance of the patients' usual inhalers (PIF) were determined within the first 48 hours of admission and prior to discharge; also assessed during a stable phase in a subgroup of patients. The results were compared and, through a multivariate study, the factors related to a suboptimal PIF were analyzed. A total of 137 patients were included; 27% were women and the mean age was 69.4 ± 9.8 years. Moreover, 30.8% of the participants with dry powder inhalers had a suboptimal PIF at admission and it was independently associated with female sex (odds ratio [OR] = 8.635; 95% confidence interval [CI] [2.007, 37.152]; < 0.01) and forced expiratory volume in the 1st second (FEV1) (OR = 0.997; 95% CI: [0.995, 0.999]; = 0.04). At discharge, suboptimal PIF reduced to 17% ( < 0.01). PIF-nr increased from the time of admission to the stable phase. One third of COPD patients admitted with a severe exacerbation had a suboptimal PIF, being female sex and lower FEV1 independent predictors. PIF-nr improved progressively after the exacerbation.
尽管在 COPD 患者中,吸入治疗时的适当峰值吸气流量(PIF)非常重要,但严重加重期患者的可用证据以及入院后的演变情况有限。我们进行这项研究,以评估加重期时的 PIF、其变异性以及 PIF 不理想的预测因素。
这是一项前瞻性研究,纳入了因 COPD 加重而入院的患者。记录了临床、人口统计学和功能变量。在入院后 48 小时内和出院前,使用 In-Check DIAL G16 测定无阻力(PIF-nr)和模拟患者常用吸入器阻力时的 PIF(PIF);在患者亚组的稳定期也进行了评估。比较了结果,并通过多变量研究分析了与 PIF 不理想相关的因素。
共纳入 137 例患者,其中 27%为女性,平均年龄为 69.4±9.8 岁。此外,30.8%使用干粉吸入器的患者入院时 PIF 不理想,且与女性性别独立相关(比值比[OR] = 8.635;95%置信区间[CI] [2.007, 37.152]; < 0.01)和第一秒用力呼气量(FEV1)(OR = 0.997;95%CI:[0.995, 0.999]; < 0.01)。出院时,PIF 不理想的比例降至 17%( < 0.01)。PIF-nr 从入院时到稳定期逐渐增加。
三分之一因严重加重而入院的 COPD 患者 PIF 不理想,女性性别和较低的 FEV1 是独立预测因素。加重后 PIF-nr 逐渐改善。